A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides difficile Infection in Individuals 18 Years of Age and Above

Study ID: 5428
NCT Number: NCT07285213
Principal Investigator: Syed Hasan Naqvi, MD
Department: Medicine Hospitalist
Eligibility: Both men and women 18 years old to 100 years old. Does not accept healthy volunteers.